The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
GnRH antagonist in assisted reproduction: a Cochrane review
Abstract
This paper is based on a Cochrane review published in The Cochrane Library, issue 1, 2002 (see www.CochraneLibrary.net for information) with permission from The Cochrane Collaboration and Update Software. Cochrane reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and The Cochrane Library should be consulted for the most recent version of the review. BACKGROUND: In the present systematic review, we wished to compare the efficacy of gonadotrophin-releasing hormone (GnRH) antagonist and GnRH agonist administration for controlled ovarian hyperstimulation in assisted conception. METHODS: Five randomized controlled trials fulfilled the inclusion criteria. In four studies, the multiple low-dose (0.25 mg) antagonist regimen was applied and, in one study, the single high-dose (3 mg) antagonist regimen was investigated. In all trials, reference treatment included a long protocol of GnRH agonist (buserelin, leuprorelin or triptorelin) starting in the mid-luteal phase of the preceding cycle. RESULTS: In comparison with the long protocol of GnRH agonist, the overall odds ratio for the prevention of premature LH surges was 1.76 [95% confidence interval (CI) 0.75–4.16], which was not statistically significant. There were significantly fewer clinical pregnancies in those treated with GnRH antagonists (OR 0.79; 95% CI 0.63–0.99). There was no statistically significant reduction in incidence of severe ovarian hyperstimulation syndrome between the two regimens (relative risk 0.51; OR 0.79; 95% CI 0.22–1.18). CONCLUSIONS: We concluded that the fixed GnRH antagonist protocol is a short and simple protocol with good clinical outcome, but the lower pregnancy rate compared with the GnRH agonist long protocol and the non-significant difference between both protocols regarding prevention of premature LH surge and prevention of severe ovarian hyperstimulation syndrome necessitates counselling subfertile couples before recommending change from GnRH agonist to antagonist. The clinical outcome may be further improved by developing more flexible antagonist regimens, taking into account individual patient characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Daya, S., Maheshwari, A., Siristatidis, C. S., Bhattacharya, S., & Gibreel, A. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001299 · Cited by 149
RetractedThe European Orgalutran® Study Group, Borm, G., & Mannaerts, B. (2000) · Human Reproduction · doi:10.1093/humrep/15.7.1490 · Cited by 376
Albano, C., Felberbaum, R. E., Smitz, J., Riethmüller-Winzen, H., Engel, J., Diedrich, K., & Devroey, P. (2000) · Human Reproduction · doi:10.1093/humrep/15.3.526 · Cited by 312
Diedrich, K., Diedrich, C., Santos, E., Zoll, C., Al-Hasani, S., Reissmann, T., Krebs, D., & Klingmüller, D. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138597 · Cited by 310
Olivennes, F., Belaisch-Allart, J., Emperaire, J.-C., Dechaud, H., Alvarez, S., Moreau, L., Nicollet, B., Zorn, J.-R., Bouchard, P., & Frydman, R. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00524-5 · Cited by 257
Embryo implantation and GnRH antagonists
Hernandez, E. R. (2000) · Human Reproduction · doi:10.1093/humrep/15.6.1211 · Cited by 187
Olivennes, F. J., Alvarez, S., Bouchard, P., Fanchin, R. R. F., Salat‐Baroux, J., & Frydman, R. (1998) · Human Reproduction · doi:10.1093/humrep/13.9.2411 · Cited by 152
Rongières-Bertrand, C., Olivennes, F., Righini, C., Fanchin, R., Taïeb, J., Hamamah, S., Bouchard, P., & Frydman, R. (1999) · Human Reproduction · doi:10.1093/humrep/14.3.683 · Cited by 141
Olivennes, F. J., Fanchin, R. R. F., Bouchard, P., de Ziegler, D., Taieb, J., Selva, J., & Frydman, R. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56933-7 · Cited by 136
Cited by
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
Delvigne, A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.559 · Cited by 717
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Multiple birth resulting from ovarian stimulation for subfertility treatment
Fauser, B. C., Devroey, P., & Macklon, N. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66478-1 · Cited by 407
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Heijnen, E. M., Eijkemans, M. J., De Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., Te Velde, E. R., Macklon, N. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60360-2 · Cited by 349
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2008) · Human Reproduction · doi:10.1093/humrep/den480 · Cited by 339
Papanikolaou, E. G., Pozzobon, C., Kolibianakis, E. M., Camus, M., Tournaye, H., Fatemi, H. M., Van Steirteghem, A., & Devroey, P. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1292 · Cited by 336
Preventing ovarian hyperstimulation syndrome: guidance for the clinician
Humaidan, P., Quartarolo, J., & Papanikolaou, E. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.028 · Cited by 321
Gonadotropin-releasing-hormone-receptor antagonists
Huirne, J. A., & Lambalk, C. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06797-6 · Cited by 319
Kolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., & Griesinger, G. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml038 · Cited by 306
Hohmann, F. P., Macklon, N. S., & Fauser, B. C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020788 · Cited by 281
Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures
Aboulghar, M. A. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg018 · Cited by 276
Pabuccu, R., Onalan, G., & Kaya, C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.046 · Cited by 90
Kolanska, K., Cohen, J., Bendifallah, S., Selleret, L., Antoine, J.-M., Chabbert-Buffet, N., Darai, E., & d’Argent, E.-M. (2017) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2017.09.007 · Cited by 42
Comparison of ovulation induction protocols after endometrioma resection
Bastu, E., Yasa, C., Dural, O., Mutlu, M. F., Celik, C., Ugurlucan, F. G., & Buyru, F. (2014) · JSLS : Journal of the Society of Laparoendoscopic Surgeons · doi:10.4293/jsls.2014.00128 · Cited by 24
Metadata
- Authors
- Al-Inany, H.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-01
- Volume
- 17
- Issue
- 4
- Pages
- 874-885
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2114603482
- Cited by
- 345
- References
- 9
- FWCI
- 28.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.